Page last updated: 2024-09-05

sch 58261 and wr-142,490

sch 58261 has been researched along with wr-142,490 in 2 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(wr-142,490)
Trials
(wr-142,490)
Recent Studies (post-2010) (wr-142,490)
46014604

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de Lera Ruiz, M; Lim, YH; Zheng, J1
Bai, R; Cai, H; Ge, J; He, X; Xie, T; Yao, C; Ye, XY; Zhong, Z; Zhu, J1

Reviews

2 review(s) available for sch 58261 and wr-142,490

ArticleYear
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Biological Products; Blood-Brain Barrier; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease

2022